Published in Antimicrob Agents Chemother on October 01, 1996
Vancomycin-resistant enterococci. Clin Microbiol Rev (2000) 5.61
Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals. Antimicrob Agents Chemother (1999) 3.04
Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microbiol (1998) 2.81
Diversity of VanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother (1998) 2.57
Development of a PCR assay for rapid detection of enterococci. J Clin Microbiol (1999) 2.09
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol (1997) 2.02
Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis (1997) 1.96
Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin. Antimicrob Agents Chemother (1998) 1.87
Historical yearly usage of vancomycin. Antimicrob Agents Chemother (1998) 1.83
Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol (1998) 1.78
Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. J Clin Microbiol (1999) 1.37
Antimicrobial drug use and resistance in dogs. Can Vet J (2002) 1.34
Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci. J Clin Microbiol (2002) 1.27
Persistence of animal and human glycopeptide-resistant enterococci on two Norwegian poultry farms formerly exposed to avoparcin is associated with a widespread plasmid-mediated vanA element within a polyclonal enterococcus faecium population. Appl Environ Microbiol (2005) 1.24
Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins. Antimicrob Agents Chemother (1999) 1.21
Friend turned foe: evolution of enterococcal virulence and antibiotic resistance. Annu Rev Microbiol (2014) 1.17
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? BMJ (2002) 1.12
Persistence of vancomycin-resistant enterococci in New Zealand broilers after discontinuation of avoparcin use. Appl Environ Microbiol (2004) 1.07
Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark. Antimicrob Agents Chemother (1999) 1.06
Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins. Antimicrob Agents Chemother (2001) 1.04
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones? Front Microbiol (2016) 1.03
Characterization of a vancomycin-resistant Enterococcus faecalis (VREF) isolate from a dog with mastitis: further evidence of a clonal lineage of VREF in New Zealand. J Clin Microbiol (2003) 1.02
Vancomycin-resistant Enterococcus spp. isolated from wastewater and chicken feces in the United States. Appl Environ Microbiol (2001) 1.02
Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol (1999) 1.00
A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand. Antimicrob Agents Chemother (2003) 0.99
From vanA Enterococcus hirae to vanA Enterococcus faecium: a study of feed supplementation with avoparcin and tylosin in young chickens. Antimicrob Agents Chemother (1999) 0.89
Antimicrobial resistance in Staphylococcus spp., Escherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermatological disorders, compared with non-treated control dogs. Acta Vet Scand (2004) 0.89
Enterococci with acquired vancomycin resistance in pigs and chickens of different age groups. Antimicrob Agents Chemother (1999) 0.87
Dogs leaving the ICU carry a very large multi-drug resistant enterococcal population with capacity for biofilm formation and horizontal gene transfer. PLoS One (2011) 0.87
Proteomic characterization of vanA-containing Enterococcus recovered from Seagulls at the Berlengas Natural Reserve, W Portugal. Proteome Sci (2010) 0.83
Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. J Clin Microbiol (1999) 0.81
Enterococcus faecium in hospitals. Eur J Clin Microbiol Infect Dis (1997) 0.81
Dogs should be included in surveillance programs for vancomycin-resistant enterococci. J Clin Microbiol (2004) 0.80
Environmental contamination by dog’s faeces: a public health problem? Int J Environ Res Public Health (2012) 0.78
Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses. Can J Vet Res (2005) 0.77
Detection of Vancomycin-Resistant Enterococcus Spp. (VRE) from Poultry. Malays J Med Sci (2001) 0.76
Gastrointestinal Colonization with Vancomycin-Resistant Enterococci In Hospitalized and Outpatients. Open Access Maced J Med Sci (2014) 0.75
Transmission dynamics of resistant bacteria in a predator-prey system. Comput Math Methods Med (2015) 0.75
VanA-type vancomycin-resistant enterococci in equine and swine rectal swabs and in human clinical samples. Curr Microbiol (2007) 0.75
Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol (1995) 12.98
Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother (1993) 5.96
Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother (1994) 4.57
Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol (1993) 4.19
Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb Drug Resist (1995) 3.14
Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother (1994) 2.85
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist (1995) 2.75
Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis (1996) 2.48
Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother (1995) 2.05
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol (1995) 2.04
Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett (1993) 1.98
Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother (1994) 1.89
vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother (1994) 1.71
Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents. Appl Environ Microbiol (1982) 1.34
Vancomycin-resistant Enterococcus durans. Lancet (1992) 1.13
Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev (1996) 6.97
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups. J Appl Bacteriol (1993) 4.19
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ (2009) 3.95
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect (2004) 3.71
Guidelines for the management of adult lower respiratory tract infections. Eur Respir J (2005) 3.51
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19
Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother (2006) 3.09
Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect (2011) 2.99
Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov. and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary specimens. Int J Syst Bacteriol (1992) 2.95
Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol (1997) 2.95
Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ (2010) 2.80
Preparedness for admission of patients with suspected Ebola virus disease in European hospitals: a survey, August-September 2014. Euro Surveill (2014) 2.65
Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol (1993) 2.54
Identification of EF group 22 campylobacters from gastroenteritis cases as Campylobacter concisus. J Clin Microbiol (1989) 2.53
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol (1999) 2.52
Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. J Infect Dis (1996) 2.51
Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J Clin Microbiol (1995) 2.43
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet (1989) 2.41
Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest (2000) 2.41
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol (2001) 2.38
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother (1985) 2.36
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill (2012) 2.29
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Application of tRNA intergenic spacer PCR for identification of Enterococcus species. J Clin Microbiol (2000) 2.27
Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system. J Clin Microbiol (1986) 2.25
Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacteriol (1996) 2.25
Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol (1995) 2.24
Riemerella anatipestifer gen. nov., comb. nov., the causative agent of septicemia anserum exsudativa, and its phylogenetic affiliation within the Flavobacterium-Cytophaga rRNA homology group. Int J Syst Bacteriol (1993) 2.24
Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol (2000) 2.20
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA (1999) 2.16
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J (2011) 2.13
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev (1997) 2.11
Arcobacter species in humans. Emerg Infect Dis (2004) 2.11
Identification of Campylobacter cinaedi isolated from blood and feces of children and adult females. J Clin Microbiol (1990) 2.10
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol (2001) 2.09
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Campylobacter upsaliensis enteritis associated with canine infections. Lancet (1991) 2.05
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol (1995) 2.04
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis (2001) 2.04
A new selective medium for the isolation of Campylobacter jejuni from human faeces. Eur J Clin Microbiol (1983) 2.03
Development of a multiplex PCR assay for the simultaneous detection and identification of Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii. FEMS Microbiol Lett (2000) 2.01
Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient. Int J Syst Evol Microbiol (2001) 1.98
Identification and characterization of Streptococcus suis. Vet Microbiol (1986) 1.97
Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. Int J Syst Evol Microbiol (2001) 1.94
Characterization and description of "Campylobacter upsaliensis" isolated from human feces. J Clin Microbiol (1990) 1.93
Differentiated Caco-2 cells as a model for enteric invasion by Campylobacter jejuni and C. coli. J Med Microbiol (1992) 1.91
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother (2000) 1.87
Flavobacterium psychrophilum infections in salmonid fish. J Fish Dis (2003) 1.84
Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol (2000) 1.82
Chemotaxonomic analyses of Bacteroides gracilis and Bacteroides ureolyticus and reclassification of B. gracilis as Campylobacter gracilis comb. nov. Int J Syst Bacteriol (1995) 1.81
Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens. J Clin Microbiol (2006) 1.73
Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples. Int J Syst Evol Microbiol (2001) 1.73
Emended description of Herbaspirillum; inclusion of [Pseudomonas] rubrisubalbicans, a milk plant pathogen, as Herbaspirillum rubrisubalbicans comb. nov.; and classification of a group of clinical isolates (EF group 1) as Herbaspirillum species 3. Int J Syst Bacteriol (1996) 1.73
Acidification of methyl-alpha-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol (1996) 1.72
Composition of the enterococcal and streptococcal intestinal flora of poultry. J Appl Bacteriol (1991) 1.69
Development of species-specific DNA probes for Campylobacter jejuni, Campylobacter coli, and Campylobacter lari by polymerase chain reaction fingerprinting. J Clin Microbiol (1993) 1.67
Utility of an internal control for the polymerase chain reaction. Application to detection of Mycoplasma pneumoniae in clinical specimens. APMIS (1992) 1.66
Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des (2003) 1.66
Burkholderia phytofirmans sp. nov., a novel plant-associated bacterium with plant-beneficial properties. Int J Syst Evol Microbiol (2005) 1.66
Bacteremia caused by a novel Bordetella species, "B. hinzii". J Clin Microbiol (1994) 1.63
Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother (2001) 1.62
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol (2003) 1.61
Clinical spectrum of infections due to the newly described Actinomyces species A. turicensis, A. radingae, and A. europaeus. J Clin Microbiol (1999) 1.61
Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol (2001) 1.61
Characterization of avian Chlamydia psittaci strains using omp1 restriction mapping and serovar-specific monoclonal antibodies. Res Microbiol (1997) 1.60
Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol (1996) 1.58
Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol (1996) 1.58
Ornithobacterium rhinotracheale gen. nov., sp. nov., isolated from the avian respiratory tract. Int J Syst Bacteriol (1994) 1.58
Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol (2006) 1.57
The effect of vaccination on the transmission of Mycoplasma hyopneumoniae in pigs under field conditions. Vet J (2010) 1.57
Performance of the recommendations of a British advisory group for screening for chlamydia in a sample of women in general practice. J Med Screen (2003) 1.56
Characteristics of different Streptococcus suis ecovars and description of a simplified identification method. Vet Microbiol (1991) 1.56
Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol (2007) 1.54
European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol (2004) 1.54
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol (1997) 1.54
Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol (2001) 1.54
Actinobacillosis in bovine caesarean sections. Vet Rec (1992) 1.54
Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect (2000) 1.54
Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int J Syst Bacteriol (1999) 1.53